FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385899808> ?p ?o ?g. }

• W4385899808 endingPage "4315" @default.
• W4385899808 startingPage "4304" @default.
• W4385899808 abstract "Glioblastoma multiforme (GBM) is the most common and lethal type of adult brain cancer. Current GBM standard of care, including radiotherapy, often ends up with cancer recurrence, resulting in limited long-term survival benefits for GBM patients. Immunotherapy, such as immune checkpoint blockade (ICB), has thus far shown limited clinical benefit for GBM patients. Therapeutic vaccines hold great potential to elicit anti-cancer adaptive immunity, which can be synergistically combined with ICB and radiotherapy. Peptide vaccines are attractive for their ease of manufacturing and stability, but their therapeutic efficacy has been limited due to poor vaccine co-delivery and the limited ability of monovalent antigen vaccines to prevent tumor immune evasion. To address these challenges, here, we report GBM radioimmunotherapy that combines radiotherapy, ICB, and multivalent lymph-node-targeting adjuvant/antigen-codelivering albumin-binding vaccines (AAco-AlbiVax). Specifically, to codeliver peptide neoantigens and adjuvant CpG to lymph nodes (LNs), we developed AAco-AlbiVax based on a Y-shaped DNA scaffold that was site-specifically conjugated with CpG, peptide neoantigens, and albumin-binding maleimide-modified Evans blue derivative (MEB). As a result, these vaccines elicited antitumor immunity including neoantigen-specific CD8+ T cell responses in mice. In orthotopic GBM mice, the combination of AAco-AlbiVax, ICB, and fractionated radiation enhanced GBM therapeutic efficacy. However, radioimmunotherapy only trended more efficacious over radiotherapy alone. Taken together, these studies underscore the great potential of radioimmunotherapy for GBM, and future optimization of treatment dosing and scheduling would improve the therapeutic efficacy." @default.
• W4385899808 created "2023-08-18" @default.
• W4385899808 creator A5009907031 @default.
• W4385899808 creator A5012556817 @default.
• W4385899808 creator A5031447537 @default.
• W4385899808 creator A5035382769 @default.
• W4385899808 creator A5046277006 @default.
• W4385899808 creator A5047550067 @default.
• W4385899808 creator A5051905350 @default.
• W4385899808 creator A5076944720 @default.
• W4385899808 creator A5084280956 @default.
• W4385899808 creator A5092654206 @default.
• W4385899808 date "2023-01-01" @default.
• W4385899808 modified "2023-10-17" @default.
• W4385899808 title "Lymph node-targeting adjuvant/neoantigen-codelivering vaccines for combination glioblastoma radioimmunotherapy" @default.
• W4385899808 cites W1840847833 @default.
• W4385899808 cites W1991701295 @default.
• W4385899808 cites W1994204471 @default.
• W4385899808 cites W2009720434 @default.
• W4385899808 cites W2042301629 @default.
• W4385899808 cites W2053393698 @default.
• W4385899808 cites W2078923880 @default.
• W4385899808 cites W2090883361 @default.
• W4385899808 cites W2108028653 @default.
• W4385899808 cites W2110223801 @default.
• W4385899808 cites W2139936109 @default.
• W4385899808 cites W2143850729 @default.
• W4385899808 cites W2152061559 @default.
• W4385899808 cites W2163895585 @default.
• W4385899808 cites W2167028666 @default.
• W4385899808 cites W2169908694 @default.
• W4385899808 cites W2179431183 @default.
• W4385899808 cites W2282550179 @default.
• W4385899808 cites W2289160872 @default.
• W4385899808 cites W2289794410 @default.
• W4385899808 cites W2541023789 @default.
• W4385899808 cites W2554773181 @default.
• W4385899808 cites W2567424265 @default.
• W4385899808 cites W2594226172 @default.
• W4385899808 cites W2613352698 @default.
• W4385899808 cites W2749747068 @default.
• W4385899808 cites W2753581915 @default.
• W4385899808 cites W2769095299 @default.
• W4385899808 cites W2783126485 @default.
• W4385899808 cites W2792075129 @default.
• W4385899808 cites W2796584001 @default.
• W4385899808 cites W2802455484 @default.
• W4385899808 cites W2811300508 @default.
• W4385899808 cites W2887370435 @default.
• W4385899808 cites W2904210127 @default.
• W4385899808 cites W2904803926 @default.
• W4385899808 cites W2909301717 @default.
• W4385899808 cites W2911752971 @default.
• W4385899808 cites W2958251376 @default.
• W4385899808 cites W2969787722 @default.
• W4385899808 cites W2980750880 @default.
• W4385899808 cites W2999404032 @default.
• W4385899808 cites W3005468192 @default.
• W4385899808 cites W3010991709 @default.
• W4385899808 cites W3012131368 @default.
• W4385899808 cites W3015150584 @default.
• W4385899808 cites W3018373832 @default.
• W4385899808 cites W3026590756 @default.
• W4385899808 cites W3028523516 @default.
• W4385899808 cites W3034695976 @default.
• W4385899808 cites W3087683890 @default.
• W4385899808 cites W3104089807 @default.
• W4385899808 cites W3111691151 @default.
• W4385899808 cites W3135011427 @default.
• W4385899808 cites W3137791784 @default.
• W4385899808 cites W3162672713 @default.
• W4385899808 cites W4224623377 @default.
• W4385899808 cites W4281661874 @default.
• W4385899808 cites W4283030510 @default.
• W4385899808 cites W4323042662 @default.
• W4385899808 doi "https://doi.org/10.7150/thno.84443" @default.
• W4385899808 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37649594" @default.
• W4385899808 hasPublicationYear "2023" @default.
• W4385899808 type Work @default.
• W4385899808 citedByCount "0" @default.
• W4385899808 crossrefType "journal-article" @default.
• W4385899808 hasAuthorship W4385899808A5009907031 @default.
• W4385899808 hasAuthorship W4385899808A5012556817 @default.
• W4385899808 hasAuthorship W4385899808A5031447537 @default.
• W4385899808 hasAuthorship W4385899808A5035382769 @default.
• W4385899808 hasAuthorship W4385899808A5046277006 @default.
• W4385899808 hasAuthorship W4385899808A5047550067 @default.
• W4385899808 hasAuthorship W4385899808A5051905350 @default.
• W4385899808 hasAuthorship W4385899808A5076944720 @default.
• W4385899808 hasAuthorship W4385899808A5084280956 @default.
• W4385899808 hasAuthorship W4385899808A5092654206 @default.
• W4385899808 hasBestOaLocation W43858998081 @default.
• W4385899808 hasConcept C126322002 @default.
• W4385899808 hasConcept C143998085 @default.
• W4385899808 hasConcept C147483822 @default.
• W4385899808 hasConcept C159654299 @default.
• W4385899808 hasConcept C203014093 @default.
• W4385899808 hasConcept C2776146153 @default.

• next